- Home
- RENB vs MATH Comparison
RENB vs MATH Comparison
Compare RENB & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- MATH
- Stock Information
- Founded
- RENB 2011
- MATH 2015
- Country
- RENB United States
- MATH Hong Kong
- Employees
- RENB N/A
- MATH N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- MATH Finance/Investors Services
- Sector
- RENB Health Care
- MATH Finance
- Exchange
- RENB Nasdaq
- MATH Nasdaq
- Market Cap
- RENB 57.7M
- MATH 60.8M
- IPO Year
- RENB N/A
- MATH N/A
- Fundamental
- Price
- RENB $0.26
- MATH $2.85
- Analyst Decision
- RENB
- MATH
- Analyst Count
- RENB 0
- MATH 0
- Target Price
- RENB N/A
- MATH N/A
- AVG Volume (30 Days)
- RENB 866.4K
- MATH 160.4K
- Earning Date
- RENB 10-09-2025
- MATH 07-30-2025
- Dividend Yield
- RENB N/A
- MATH N/A
- EPS Growth
- RENB N/A
- MATH N/A
- EPS
- RENB N/A
- MATH 0.41
- Revenue
- RENB N/A
- MATH $44,567,257.00
- Revenue This Year
- RENB N/A
- MATH N/A
- Revenue Next Year
- RENB N/A
- MATH N/A
- P/E Ratio
- RENB N/A
- MATH $7.15
- Revenue Growth
- RENB N/A
- MATH 165.86
- 52 Week Low
- RENB $0.22
- MATH $0.80
- 52 Week High
- RENB $2.10
- MATH $4.17
- Technical
- Relative Strength Index (RSI)
- RENB 51.07
- MATH 44.68
- Support Level
- RENB $0.22
- MATH $2.71
- Resistance Level
- RENB $0.25
- MATH $2.99
- Average True Range (ATR)
- RENB 0.02
- MATH 0.21
- MACD
- RENB 0.00
- MATH 0.02
- Stochastic Oscillator
- RENB 84.44
- MATH 39.78
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.